Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02964494 · ClinicalTrials.gov registry record

The Congenital Dyserythropoietic Anemia Registry (CDAR)

A clinical trial of Congenital Dyserythropoietic Anemia (CDA), sponsored by Children's Hospital Medical Center, Cincinnati.

Recruiting
Registry status
10,000
Enrollment target
1
Study location

NCT02964494 is a study of Congenital Dyserythropoietic Anemia (CDA) that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 10,000 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02964494, a study of Congenital Dyserythropoietic Anemia (CDA), is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.

RECRUITING
Registry status
10,000 participants
Enrollment target
1
Study location

Study Summary

The investigators have created and maintain a comprehensive registry for patients with the diagnosis of Congenital Dyserythropoietic Anemia (CDA) in North America. The goal of this registry is to collect long-term confidential data on patients with CDA in the US, Canada, and Mexico and maintain a bio-repository of de-identified patient blood and bone marrow specimens as a tool for the investigation of epidemiology, natural history, biology, and molecular pathogenetic mechanisms of CDA.

Study Locations (1)

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2016-08-29
Est. Completion 2031-01

What the Registry Record Tells You About NCT02964494

The ClinicalTrials.gov registry entry for NCT02964494 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Congenital Dyserythropoietic Anemia (CDA) appearing as the primary indexed condition, and to 0 interventions.

NCT02964494 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02964494 about?

NCT02964494 is a clinical study titled "The Congenital Dyserythropoietic Anemia Registry (CDAR)". The investigators have created and maintain a comprehensive registry for patients with the diagnosis of Congenital Dyserythropoietic Anemia (CDA) in North America. The goal of this registry is to collect long-term confidential data on patients with CDA in the US, Canada, and Mexico and maintain a bi...

What is the current status of trial NCT02964494?

This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2016-08-29. Estimated completion is 2031-01.

What conditions does trial NCT02964494 study?

This clinical trial studies the following conditions: Congenital Dyserythropoietic Anemia (CDA).

Who is sponsoring clinical trial NCT02964494?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02964494 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.